-+ 0.00%
-+ 0.00%
-+ 0.00%

Spago Nanomedical Shareholders Approve Delisting Application at Extraordinary Meeting

PUBT·11/19/2026 13:22:57
Listen to the news
Spago Nanomedical Shareholders Approve Delisting Application at Extraordinary Meeting
  • Spago Nanomedical shareholders approved the board's delisting application resolution for Nasdaq First North Growth Market at the November 19, 2026, extraordinary meeting.
  • The preliminary timetable schedules the application for January 25, 2027, with a decision expected in January 2027.
  • Subject to approval, trading would end in February 2027, no earlier than two weeks following Nasdaq Stockholm's decision.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spago Nanomedical AB published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.